This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Neonatal aspiration syndromes
P16_NEONTAL_ASPIRATI_SYNDR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
45 |
4. Check minimum number of eventsNone |
45 |
5. Include endpointsNone |
45 |
6. Filter based on genotype QC (FinnGen only) |
45 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Syndroma aspirationis neonatorum
Similar endpoints
↥List of similar endpoints to
Neonatal aspiration syndromes
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3059 | 1560 | 1499 |
| Only index persons | 1802 | 902 | 900 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45 | 29 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
5
18
2.99
1.32
1.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
107
0.40
1.21
1.2
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
144
0.46
1.21
1.8
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
62
2.02
1.05
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
30
0.00
1.01
0.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
32
0.00
0.99
0.0
1.2
—
21.4
—
0
7
(3005322) IgE [Units/volume] in Serum or Plasma
6
31
2.08
0.88
1.3
1.4
u/ml
170.8
791.6
—
6
31
(3023368) Bacteria identified in Blood by Culture
8
47
1.85
0.86
2.9
5.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
48
1.81
0.84
1.6
3.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
26
0.00
0.81
0.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
55
1.79
0.80
1.3
2.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
60
1.86
0.80
1.6
2.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
26
2.03
0.73
19.4
27.6
mg/l
0.9
1.0
—
5
26
(3000764) Benzodiazepines [Presence] in Urine
10
62
1.79
0.72
1.6
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
62
1.79
0.72
1.6
2.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
43
1.74
0.70
4.0
6.3
mmol/l
24.1
24.3
—
7
43
(3028300) Cannabinoids [Presence] in Urine
10
63
1.76
0.68
1.6
2.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
49
1.77
0.67
1.4
2.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
20
0.00
0.62
0.0
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.62
0.0
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
19
0.00
0.62
0.0
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
22
0.00
0.61
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
35
1.82
0.60
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
140
0.63
0.54
2.1
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
45
1.66
0.52
4.0
6.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
84
0.55
0.51
1.6
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
48
1.54
0.50
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
91
0.61
0.48
1.7
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15
188
0.70
0.46
1.8
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
37
339
1.51
0.44
19.0
13.0
%
38.3
39.4
0.30
29
288
(40761536) Microorganisms panel - Urine sediment
5
32
1.63
0.44
1.8
4.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
16
0.00
0.42
0.0
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
34
1.53
0.42
1.4
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
17
0.00
0.41
0.0
2.7
—
0.2
—
0
17
(42870588) Differential panel, method unspecified - Blood
16
129
1.37
0.37
12.1
9.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
15
180
0.75
0.32
2.3
2.6
mmol/l
1.2
1.2
0.10
15
170
(36304419) Bacteria [Presence] in Urine
11
85
1.39
0.32
3.1
5.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
65
1.28
0.29
2.9
3.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
28
306
0.78
0.27
15.8
11.7
mmol/l
139.1
139.6
0.21
28
296
(3015377) Calcium [Moles/volume] in Serum or Plasma
9
76
1.23
0.27
2.3
2.4
mmol/l
2.4
2.4
—
9
69
(3023103) Potassium [Moles/volume] in Serum or Plasma
28
305
0.78
0.26
15.0
11.7
mmol/l
4.0
3.9
0.69
28
294
(40761511) CBC panel - Blood by Automated count
33
352
0.77
0.24
6.5
7.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
40
1.28
0.23
2.2
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
11.7
—
0.3
—
0
6
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
20
223
0.81
0.21
7.5
6.7
ml/min/173m2
115.9
116.1
0.01
12
156
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
50
1.23
0.21
29.3
15.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
17
192
0.82
0.20
2.0
2.3
mmol/l
1.4
1.4
0.30
17
180
(3044640) Blood type and Crossmatch panel - Blood
10
82
1.28
0.19
2.8
3.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
82
1.28
0.19
3.3
4.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
148
0.83
0.15
1.8
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
13
113
1.21
0.15
3.3
5.8
e6/l
8.2
35.5
—
8
80
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
15
167
0.85
0.13
2.4
2.6
mmol/mol
31.4
35.3
2.88
15
151
(3044889) 12 lead EKG panel
12
136
0.84
0.13
3.0
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
18
196
0.86
0.12
2.0
2.4
mmol/l
4.4
4.3
0.16
18
184
(3003694) ABO and Rh group [Type] in Blood
14
127
1.15
0.09
1.4
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
56
1.08
0.09
6.0
12.9
mmol/l
24.2
25.1
—
6
56
(3012544) pH of Venous blood
6
56
1.08
0.09
5.8
11.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
61
0.80
0.09
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
64
0.75
0.09
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
38
383
0.95
0.08
4.6
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
19
203
0.89
0.08
22.0
10.1
e9/l
2.9
3.9
2.31
19
175
(40768804) Tissue Pathology biopsy report
6
73
0.79
0.08
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
14
128
1.14
0.08
3.4
4.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
9
83
1.11
0.08
1.2
3.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
100
0.88
0.07
1.4
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
103
0.84
0.07
1.2
3.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
18
191
0.90
0.06
2.1
2.4
mmol/l
2.8
2.6
0.70
18
176
(40758558) Short blood count panel - Blood
11
101
1.12
0.04
16.8
10.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
21
201
1.08
0.04
3.8
4.6
—
—
—
0
0
(3015736) pH of Urine
10
107
0.92
0.02
1.4
3.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
19
191
0.99
0.00
13.6
8.8
%
36.9
34.1
0.56
19
185
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
17
167
1.03
0.00
2.2
3.4
u/l
20.7
24.4
0.39
17
161
(3006504) Eosinophils/100 leukocytes in Blood
18
177
1.03
0.00
14.2
9.3
%
3.2
3.1
0.06
18
167
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
95
1.07
0.00
1.6
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
105
1.06
0.00
3.1
5.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
144
0.96
0.00
1.1
1.6
g/l
1.4
1.6
—
9
74
(3018010) Neutrophils/100 leukocytes in Blood
19
186
1.04
0.00
13.6
8.7
%
45.8
51.2
0.93
19
178
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.6
—
1.1
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
9
0.00
0.00
0.0
6.8
—
4.9
—
0
9
(3024928) Oxygen saturation in Venous blood
0
6
0.00
0.00
0.0
28.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
9
0.00
0.00
0.0
2.7
—
53.1
—
0
9
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
1.1
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
34
340
1.00
0.00
8.9
10.1
mg/l
21.8
22.7
0.05
23
236
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
18
180
1.00
0.00
14.3
9.2
%
9.3
8.1
1.45
18
172
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
18.8
—
0
6
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
29.7
—
0
7
(3018405) Lactate [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
2.1
—
1.3
—
0
8
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
3.6
—
0
6
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
7
0.00
0.00
0.0
25.1
—
77.2
—
0
7
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
35.8
—
150.0
—
0
5
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
1.9
—
0
7
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
6.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
1.1
—
213.1
—
0
8
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.6
—
9.4
—
0
5
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
4.0
—
47.1
—
0
9
(3027315) Oxygen [Partial pressure] in Blood
0
9
0.00
0.00
0.0
6.8
—
10.1
—
0
9
(44790048)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
9
89
1.01
0.00
1.3
2.4
mg/l
2.2
2.5
—
9
75
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
7.1
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(44806118)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
0.00
0.0
4.0
—
3.0
—
0
9
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
32.6
—
12.6
—
0
5
(3028271) Lactate [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
2.9
—
2.4
—
0
8
(3020891) Body temperature
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
6
60
1.00
0.00
2.3
2.5
u/l
—
3328.2
—
0
21
(3022806) Fractional oxyhemoglobin in Capillary blood
0
8
0.00
0.00
0.0
2.1
—
94.2
—
0
8
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(42870560) Thyrotropin [Units/volume] in Cord blood
0
8
0.00
0.00
0.0
1.0
—
8.9
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
92.2
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
6
0.00
0.00
0.0
12.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
7.7
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(44790049)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3010421) pH of Blood
0
9
0.00
0.00
0.0
6.8
—
7.4
—
0
9
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_NEONTAL_ASPIRATI_SYNDR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_NEONTAL_ASPIRATI_SYNDR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_NEONTAL_ASPIRATI_SYNDR – Neonatal aspiration syndromes
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data